Methylsulfonylmethane (msm) supplements market to reach $2.07 billion by 2030 at 8.9% CAGR, driven by increase in prevalence of joint disorders and rise in aging population.
Read More
Methicillin-resistant staphylococcus aureus (mrsa) drugs market to reach $3.25 billion by 2030 at 6.0% CAGR, driven by rising hospital acquired infections.
Read More
Methenamine hippurate tablets market to reach $14.49 billion by 2030 at 7.5% CAGR, driven by rising cases of urinary tract infections and rising healthcare expenditure.
Read More
Metastatic cancer drugs market to reach $79.32 billion by 2030 at 5.8% CAGR, driven by evolution of precision medicine and personalized therapies.
Read More
Messenger ribonucleic acid quality monitoring market to reach $2.49 billion by 2030 at 11.0% CAGR, driven by increasing demand for personalized medicines.
Read More
Messenger ribonucleic acid (mrna) synthesis raw materials market to reach $3.65 billion by 2030 at 4.0% CAGR, driven by growing incidence of cancer and chronic disorders.
Read More
Messenger ribonucleic acid (mrna) synthesis and manufacturing market to reach $9.22 billion by 2030 at 12.3% CAGR, driven by increasing prevalence of infectious diseases.
Read More
Messenger ribonucleic acid (mrna) capping enzyme market to reach $1.97 billion by 2030 at 14.1% CAGR, driven by growing adoption of personalized medicine.
Read More
Men’s health supplements market to reach $148.91 billion by 2030 at 11.4% CAGR, driven by increase in disposable income.
Read More
Menopause supplement market to reach $2.98 billion by 2030 at 7.7% CAGR, driven by rising prevalence of menopausal symptoms.
Read More